CV vs CVS · rev $3.5M vs P/E 16, rev $402.07B
CapsoVision, Inc. Common Stock (CV) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
CV currently screens at market cap $359.2M. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the CV and CVS stock pages for the full models.
Not investment advice.